Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Q&A: IMDRF Releases Final Legacy Device Cybersecurity Guidance

Executive Summary

The International Medical Device Regulation Forum published its final guidance on principles and practices for legacy medical devices, and the document seems to be less about legacy devices and more about the total lifecycle of a device, compliance expert Eric Henry told Medtech insight.

You may also be interested in...



Cox Survey Finds Federal Regulations Are Lowest Barrier To Becoming A ‘Smart Hospital’

Medtech Insight spoke to Cox Communications VP George Valentine about the main obstacles facing hospitals trying to become “smart hospitals.”

Latest Cybersecurity Guidance From IMDRF Highlights Software Bills Of Materials

In its latest cybersecurity guidance document, the International Medical Device Regulation Forum outlines why medical device manufacturers should ensure that each component of their device is cybersecure and how this can be done.

TEAM-NB Survey Shows Slow But Promising Progress Towards MDR/IVDR Certification

Manufacturers are creating their own delays by failing to submit the correct technical documentation to notified bodies. Nevertheless, the latest Medical Device Regulation amendment looks set to ensure compliance against new deadlines is tenable, a recent survey shows.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147822

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel